PM Eastern Time, today. MONROVIA, CA / ACCESS Newswire / May 12, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock ...

PersonnelChanges to the Medios AG Executive Board; Matthias Gärtner will leave the company12-May-2025 / 18:56 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) ...

Seven countries take center stage as new survey results reveal which national health systems are fast-tracking - or falling behind - in digital health transformation. NEW YORK CITY, NEW YORK / ACCESS ...

The use of Ovaterra supplements with DHEA and other key active ingredients may provide necessary support for ovarian function, prenatal wellness, and reproductive health, especially for women over 40 ...

Experienced Medtech Executive to Lead EDGe Surgical Through Commercial Scale-Up and Product Line Expansion CHICAGO, ILLINOIS / ACCESS Newswire / May 12, 2025 / EDGe Surgical, a medical device company ...

POTOMAC, MD / ACCESS Newswire / May 12, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company") today announced that it presented its latest scientific poster, titled "Genetic Toxicity ...

BEIJING, CHINA / ACCESS Newswire / May 12, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and ...

Genomate Health, a leading precision oncology company, today announced its formal entry into the U.S. market during the SelectUSA Investment Summit, the premier event for international companies ...

MUNICH, DE / ACCESS Newswire / May 12, 2025 / Secarna Pharmaceuticals GmbH & Co. KG, a company redefining the discovery and development of best-in-class oligonucleotide therapeutics, today announced ...

Q1 revenues increased 412% year over year, driven by AI Nose productsDelivers strong turnaround from gross loss to gross profit in Q1AI Nose gains traction beyond healthcare with strategic ...

Funding will enable company to expand research capacity and scale up unique genome editing technology designed to treat complex, rare diseases while also opening new avenues for protein bioproduction ...

The global drug discovery enzymes market is poised for significant expansion, projected to grow from USD 932.4 million in 2023 to USD 1,751.3 million by 2033, advancing at a compound annual growth ...